Schedule 13G ownership disclosure

Biodel Inc

Security class unavailable · CUSIP: 09064M105

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,061,003
Percent of class
8.7900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000028
Form type
SC 13G/A
Filer
ALBIREO PHARMA, INC.
CIK
CIK 1322505
Filed
Jan 12, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub